Page last updated: 2024-12-06

di-2-ethylhexyl sebacate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Di-2-ethylhexyl sebacate (DEHS) is a synthetic plasticizer, a type of chemical added to plastics to increase their flexibility and durability. It is a clear, colorless, and odorless liquid. DEHS is produced by the esterification reaction of sebacic acid with 2-ethylhexanol. DEHS is widely used in various applications, including PVC (polyvinyl chloride) products such as flooring, wall coverings, and vinyl toys. It is also used in adhesives, sealants, and cosmetics. DEHS is a non-volatile, non-flammable, and bio-compatible compound. It is generally considered safe for use in many applications, although concerns exist regarding its potential health effects. Research indicates that DEHS can be absorbed through the skin and inhaled, leading to potential adverse effects on the reproductive system, liver, and thyroid gland. Studies on DEHS focus on its potential environmental impact, its effects on human health, and alternative plasticizers that may be safer. The research aims to understand its fate in the environment, its persistence, and potential bioaccumulation in organisms. In addition, research explores potential health risks associated with DEHS exposure and investigates alternative plasticizers that are safer and less harmful to human health and the environment.'

Cross-References

ID SourceID
PubMed CID31218
CHEMBL ID3187356
SCHEMBL ID37169
MeSH IDM0113710

Synonyms (99)

Synonym
LS-15168
usaf ke-2
di-2-ethylhexyl isosebacate
isosebacic acid, di-2-ethylhexyl ester
dos ,
di(2-ethylhexyl) sebacate
reolube dos
monoplex dos
decanedioic acid, bis(2-ethylhexyl) ester
1-hexanol, sebacate
nsc68878
staflex dos
bisoflex dos
plexol
bis(2-ethylhexyl) decanedioate
bis(2-ethylhexyl) sebacate
edenol 888
sebacic acid bis(2-ethylhexyl) ester
wln: 4y2 & 1ov8vo1y4 & 2
2-ethylhexyl sebacate
bisoflex
sebacic acid, bis(2-ethylhexyl) ester
bis(ethylhexyl) sebacate
octoil s
nsc-68878
plexol 201j
122-62-3
px 438
bis-(2-ethylhexyl)ester kyseliny sebakove [czech]
uniflex dos
sebacic acid, di-2-ethylhexyl diester
bis(2-ethylhexyl)sebacate ,
edenor dehs
ai3-09124
reomol dds
einecs 204-558-8
brn 1806504
dioctyl sebacate (van)
1-hexanol, 2-ethyl-, sebacate
ccris 6191
ergoplast sdo
hsdb 2898
di-2-ethylhexyl sebacate
sebacic acid, bis(2-ethylhexyl)ester
nsc 68878
bis(2-ethylhexyl)decanedioate
sansocizer dos
bis(2-ethylhexyl) sebacate, technical grade, 90%
di(2-ethylhexyl)sebacate
bis(2-ethylhexyl) sebacate, >=97.0% (gc)
S0025
diethylhexyl sebacate
unii-u9ls47q72q
decanedioic acid, 1,10-bis(2-ethylhexyl) ester
4-02-00-02083 (beilstein handbook reference)
u9ls47q72q ,
bis-(2-ethylhexyl)ester kyseliny sebakove
ec 204-558-8
dtxsid7025055 ,
NCGC00257416-01
cas-122-62-3
tox21_303439
dtxcid005055
c26h50o4
29590-28-1
sebacic acid di(2-ethylhexyl) ester
FT-0631704
AKOS015903925
diethylhexyl sebacate [inci]
hallstar dos
aec diethylhexyl sebacate
diethylhexyl sebacate, (+/-)-
dub dos
hatcol 5110
bis(2-ethylhexyl) sebacate [hsdb]
(+/-)-diethylhexyl sebacate
bis(2-ethylhexyl) sebacate [mi]
SCHEMBL37169
CHEMBL3187356
plexol 201
bis(2-ethylhexyl) ester, decanedionic acid
behs
ergoplast sno
plasthall dos
decanedioic acid, di-(2-ethylhexyl) ester
bis(2-ethylhexyl) ester, sebacic acid
J-004836
bis(2-ethylhexyl) sebacate, selectophore(tm), >=97.0%
mfcd00009497
decanedioic acid bis(2-ethylhexyl) ester
decanedioic acid, 1,10-bis (2-ethylhexyl) ester
Q4387284
sebacic acid bis (2_ethylhexyl) ester
decanedioic acid bis(2_ethylhexyl) ester
bis(2_ethylhexyl)sebacate
AT25397
CS-0152375
1,10-bis(2-ethylhexyl) decanedioate
dioctyl sebacate 99%

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Reactivity to MCH was expressed as the dose-response slope; it was calculated as percent final change in FEV1/cumulative dose MCH inhaled."( Intersubject variability in particle deposition does not explain variability in responsiveness to methacholine.
Anderson, PJ; Blanchard, JD; Brain, JD; Feldman, HA; Garshick, E, 1991
)
0.28
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (3)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
RAR-related orphan receptor gammaMus musculus (house mouse)Potency6.85900.006038.004119,952.5996AID1159521
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency27.30600.001530.607315,848.9004AID1224841; AID1259401
estrogen nuclear receptor alphaHomo sapiens (human)Potency3.06380.000229.305416,493.5996AID743079
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (33)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (12.12)18.7374
1990's8 (24.24)18.2507
2000's7 (21.21)29.6817
2010's11 (33.33)24.3611
2020's3 (9.09)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 28.03

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index28.03 (24.57)
Research Supply Index3.61 (2.92)
Research Growth Index4.79 (4.65)
Search Engine Demand Index30.30 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (28.03)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (2.86%)5.53%
Reviews2 (5.71%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other32 (91.43%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]